SEC Filings

10-Q
MEDTRONIC PLC filed this Form 10-Q on 12/04/2017
Entire Document
 
Medtronic plc
Notes to Consolidated Financial Statements
(Unaudited)


Consolidating Statement of Comprehensive Income
Six Months Ended October 28, 2016
CIFSA Senior Notes
(in millions)
Medtronic plc
 
CIFSA
 
CIFSA Subsidiary Guarantors
 
Subsidiary Non-guarantors
 
Consolidating
Adjustments
 
Total
Net sales
$

 
$

 
$

 
$
14,511

 
$

 
$
14,511

 
 
 
 
 
 
 
 
 
 
 
 
Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of products sold

 

 

 
4,587

 

 
4,587

Research and development expense

 

 

 
1,110

 

 
1,110

Selling, general, and administrative expense
6

 

 
1

 
4,837

 

 
4,844

Amortization of intangible assets

 

 

 
987

 

 
987

Restructuring charges, net

 

 

 
141

 

 
141

Certain litigation charges

 

 

 
82

 

 
82

Acquisition-related items

 

 

 
80

 

 
80

Other (income) expense, net
(74
)
 

 

 
202

 

 
128

Operating profit (loss)
68

 

 
(1
)
 
2,485

 

 
2,552

Interest income

 
(47
)
 
(324
)
 
(207
)
 
394

 
(184
)
Interest expense
41

 
56

 
13

 
820

 
(394
)
 
536

Interest expense, net
41

 
9

 
(311
)
 
613

 

 
352

Equity in net (income) loss of subsidiaries
(2,013
)
 
(1,249
)
 
(1,703
)
 

 
4,965

 

Income before income taxes
2,040

 
1,240

 
2,013

 
1,872

 
(4,965
)
 
2,200

Income tax (benefit) provision
(4
)
 

 

 
164

 

 
160

Net income
2,044

 
1,240

 
2,013

 
1,708

 
(4,965
)
 
2,040

Net loss attributable to noncontrolling interests

 

 

 
4

 

 
4

Net income attributable to Medtronic
2,044

 
1,240

 
2,013

 
1,712

 
(4,965
)
 
2,044

Other comprehensive income (loss), net of tax
(460
)
 
19

 
(460
)
 
(460
)
 
901

 
(460
)
Other comprehensive loss attributable to
non-controlling interests

 

 

 
4

 

 
4

Total comprehensive income
$
1,584

 
$
1,259

 
$
1,553

 
$
1,252

 
$
(4,064
)
 
$
1,584




47

X